Search results

|title=Distelmaier F, Valsecchi F, Forkink M, van Emst-de Vries S, Swarts HG, Rodenburg RJ, Verwiel ET, Smeitink JA, Willems PH, Koopman WJ ( |authors=Distelmaier F, Valsecchi F, Forkink M, van Emst-de Vries S, Swarts HG, Rodenburg RJ, Verwiel ET, Smeitink JA, Willems PH, Koopman WJ

...Einer C, Distelmaier F, Groh L, van Emst-de Vries SE, van de Westerlo E, van de Wal M, Wagenaars J, Rodenburg RJ, Smeitink JAM, Riksen NP, Willems PGHM ...Einer C, Distelmaier F, Groh L, van Emst-de Vries SE, van de Westerlo E, van de Wal M, Wagenaars J, Rodenburg RJ, Smeitink JAM, Riksen NP, Willems PGHM

...ensors will be discussed using examples from the literature and the author’s own research [1,2,3,4,5,6]. ...E, Schöckel L, Bossenbroek HM, van Emst-de Vries SE, Hermeling JCW, Grefte S, Kopitz C, Heroult M, Willems PHGM, Koopman WJH (2017) Mitochondrial compl

...rkinson’s disease, cancer, cardiac disease, diabetes, epilepsy, Huntington’s disease, and obesity. In addition, mitochondrial function is inhibited by e # Distelmaier F, Valsecchi F, Forkink M, van Emst-de Vries S, Swarts H, Rodenburg R, Verwiel E, Smeitink J, Willems PHGM, Koopman WJH (2

...mon pathologic conditions, such as Alzheimer’s, Huntington’s and Parkinson’s disease, cancer, cardiac disease, diabetes, epilepsy, and obesity. In addit # Distelmaier F, Valsecchi F, Forkink M, Van Emst-de Vries S, Swarts H, Rodenburg R, Verwiel E, Smeitink J, Willems PHGM, Koopman WJH (2

:::#Blanchet L, Smeitink JAM, Breuer ME, van Emst - de Vries SE, Vogels C, Pellegrini M, Jonckheere AI, Rodenburg RJT, Buydens LMC, Beyr :::#Koopman WJH, Beyrath J, Fung W, Koene S, Rodenburg RR, Willems PHGM, Smeitink JAM (2016) Mitochondrial disorders in